Filip Janku - 23 Feb 2026 Form 4 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)

Signature
/s/ Markus Warmuth, Attorney-in-Fact
Issuer symbol
GLUE
Transactions as of
23 Feb 2026
Net transactions value
-$179,161
Form type
4
Filing time
24 Feb 2026, 16:05:11 UTC
Previous filing
05 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Janku Filip Chief Medical Officer MONTE ROSA THERAPEUTICS, INC., 321 HARRISON AVENUE, SUITE 900, BOSTON /s/ Markus Warmuth, Attorney-in-Fact 24 Feb 2026 0001862930

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLUE Common Stock Sale $179,161 -9,189 -12% $19.50 65,837 23 Feb 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.